NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide

Clinical trial NCT05558319 · RECRUITING

Trial details

NCT number: NCT05558319
Sponsor: PETHEMA Foundation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Newly Diagnosed Multiple Myeloma

Start date: 2022-11-10
Primary completion: 2027-04-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.